+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Chronic Myelogenous Leukemia Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 146 Pages
  • October 2024
  • Region: Global
  • TechNavio
  • ID: 5654471
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The chronic myelogenous leukemia therapeutics market is forecasted to grow by USD 1.93 billion during 2023-2028, accelerating at a CAGR of 5.6% during the forecast period. The report on the chronic myelogenous leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advent of novel therapies, patient assistance programs for tkis, and strategic alliances.

The chronic myelogenous leukemia therapeutics market is segmented as below:

By Product

  • Targeted therapy
  • Chemotherapy
  • Immunotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of pipeline molecules as one of the prime reasons driving the chronic myelogenous leukemia therapeutics market growth during the next few years. Also, development of diagnostic tests and predictive markers and increasing research in regenerative medicines will lead to sizable demand in the market.

The report on the chronic myelogenous leukemia therapeutics market covers the following areas:

  • Chronic Myelogenous Leukemia Therapeutics Market sizing
  • Chronic Myelogenous Leukemia Therapeutics Market forecast
  • Chronic Myelogenous Leukemia Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic myelogenous leukemia therapeutics market vendors that include Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Innovent Biologics Inc., Lupin Ltd., Merck KGaA, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sheba Medical Center, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the chronic myelogenous leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Chronic Myelogenous Leukemia Therapeutics Market 2018 - 2022
  • Historic Market Size - Data Table on Global Chronic Myelogenous Leukemia Therapeutics Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
  • Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
  • Chart on Product - Market share 2023-2028 (%)
  • Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
6.3 Targeted therapy - Market size and forecast 2023-2028
  • Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
6.4 Chemotherapy - Market size and forecast 2023-2028
  • Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
6.5 Immunotherapy - Market size and forecast 2023-2028
  • Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)
7 Customer Landscape
7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
  • Overview on factors of disruption
10.4 Industry risks
  • Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
  • Companies covered
11.2 Market positioning of companies
  • Matrix on companies position and classification
11.3 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
11.4 Bristol Myers Squibb Co.
  • Bristol Myers Squibb Co. - Overview
  • Bristol Myers Squibb Co. - Product / Service
  • Bristol Myers Squibb Co. - Key news
  • Bristol Myers Squibb Co. - Key offerings
11.5 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
11.6 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
11.7 Otsuka Holdings Co. Ltd.
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key news
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Segment focus
11.8 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
11.9 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
11.10 Takeda Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd. - Overview
  • Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Takeda Pharmaceutical Co. Ltd. - Key news
  • Takeda Pharmaceutical Co. Ltd. - Key offerings
11.11 Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key news
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Segment focus
11.12 Viatris Inc.
  • Viatris Inc. - Overview
  • Viatris Inc. - Business segments
  • Viatris Inc. - Key news
  • Viatris Inc. - Key offerings
  • Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
12.4 Research methodology
  • Research methodology
12.5 Data procurement
  • Information sources
12.6 Data validation
  • Data validation
12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
12.8 Data synthesis
  • Data synthesis
12.9 360 degree market analysis
  • 360 degree market analysis
12.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Chronic Myelogenous Leukemia Therapeutics Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 43: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits 44: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Product ($ million)
Exhibits 47: Data Table on Market opportunity by Product ($ million)
Exhibits 48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 49: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 51: Chart on Geographic comparison
Exhibits 52: Data Table on Geographic comparison
Exhibits 53: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 89: Market opportunity By Geographical Landscape ($ million)
Exhibits 90: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 91: Impact of drivers and challenges in 2023 and 2028
Exhibits 92: Overview on criticality of inputs and factors of differentiation
Exhibits 93: Overview on factors of disruption
Exhibits 94: Impact of key risks on business
Exhibits 95: Companies covered
Exhibits 96: Matrix on companies position and classification
Exhibits 97: Boehringer Ingelheim International GmbH - Overview
Exhibits 98: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 99: Boehringer Ingelheim International GmbH - Key news
Exhibits 100: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 101: Bristol Myers Squibb Co. - Overview
Exhibits 102: Bristol Myers Squibb Co. - Product / Service
Exhibits 103: Bristol Myers Squibb Co. - Key news
Exhibits 104: Bristol Myers Squibb Co. - Key offerings
Exhibits 105: Merck KGaA - Overview
Exhibits 106: Merck KGaA - Business segments
Exhibits 107: Merck KGaA - Key news
Exhibits 108: Merck KGaA - Key offerings
Exhibits 109: Merck KGaA - Segment focus
Exhibits 110: Novartis AG - Overview
Exhibits 111: Novartis AG - Business segments
Exhibits 112: Novartis AG - Key news
Exhibits 113: Novartis AG - Key offerings
Exhibits 114: Novartis AG - Segment focus
Exhibits 115: Otsuka Holdings Co. Ltd. - Overview
Exhibits 116: Otsuka Holdings Co. Ltd. - Business segments
Exhibits 117: Otsuka Holdings Co. Ltd. - Key news
Exhibits 118: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits 119: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits 120: Pfizer Inc. - Overview
Exhibits 121: Pfizer Inc. - Product / Service
Exhibits 122: Pfizer Inc. - Key news
Exhibits 123: Pfizer Inc. - Key offerings
Exhibits 124: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 125: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 126: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 127: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 128: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits 129: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits 130: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits 131: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits 132: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 133: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 134: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 135: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 136: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 137: Viatris Inc. - Overview
Exhibits 138: Viatris Inc. - Business segments
Exhibits 139: Viatris Inc. - Key news
Exhibits 140: Viatris Inc. - Key offerings
Exhibits 141: Viatris Inc. - Segment focus
Exhibits 142: Inclusions checklist
Exhibits 143: Exclusions checklist
Exhibits 144: Currency conversion rates for US$
Exhibits 145: Research methodology
Exhibits 146: Information sources
Exhibits 147: Data validation
Exhibits 148: Validation techniques employed for market sizing
Exhibits 149: Data synthesis
Exhibits 150: 360 degree market analysis
Exhibits 151: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global chronic myelogenous leukemia therapeutics market: Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Innovent Biologics Inc., Lupin Ltd., Merck KGaA, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Sheba Medical Center, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is emergence of pipeline molecules."

According to the report, one of the major drivers for this market is the advent of novel therapies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amneal Pharmaceuticals Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Dr Reddys Laboratories Ltd.
  • F. Hoffmann La Roche Ltd.
  • Innovent Biologics Inc.
  • Lupin Ltd.
  • Merck KGaA
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Sheba Medical Center
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.